Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-07-15 @ 5:27 PM
Study NCT ID:
NCT01900002
Status:
COMPLETED
Last Update Posted:
2021-12-30
First Post:
2013-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Adult Hepatocellular Carcinoma | View |
| None | BCLC Stage C Hepatocellular Carcinoma | View |
| None | Recurrent Adult Hepatocellular Carcinoma | View |
| None | Stage III Hepatocellular Carcinoma AJCC v7 | View |
| None | Stage IIIA Hepatocellular Carcinoma AJCC v7 | View |
| None | Stage IIIB Hepatocellular Carcinoma AJCC v7 | View |
| None | Stage IIIC Hepatocellular Carcinoma AJCC v7 | View |
| None | Stage IV Hepatocellular Carcinoma AJCC v7 | View |
| None | Stage IVA Hepatocellular Carcinoma AJCC v7 | View |
| None | Stage IVB Hepatocellular Carcinoma AJCC v7 | View |
| None | Unresectable Hepatocellular Carcinoma | View |
Keywords: